PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Therion Biologics Corporation
ClinicalTrials.gov Identifier:
NCT00078585
First received: March 1, 2004
Last updated: July 7, 2005
Last verified: July 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Study Completion Date: No date given
  Primary Completion Date: No date given